Searched for
COVID VACCINE COVOVAX
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...- Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsLast month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- SII gets govt nod to export 32.4 lakh doses of Covovax vaccine to USIn a letter to the government on June 29, Prakash Kumar Singh, director (government and regulatory affairs) at SII had sought permission to...
- SII seeks nod to export 32.4 lakh doses of its Covid vaccine Covovax to USIt will be the first instance of any Indian manufacturer's vaccine -- Covid or non-Covid -- to be exported to the US. According to a commun...
- SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold in EuropePoonawalla, in an exclusive interview with ANI, said, "We have a stockpile of 200 million doses of Covishield...We've already exported 40 m...
- Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and aboveThe COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...
- NTAGI's Covid working group to review SII's Covovax data for use in 12 year olds and aboveIndia's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years a...
- India's drugs regulator gives nod to phase-3 clinical trial of Covid vaccine CovovaxCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- DCGI's EUA nod to SII's Covovax for 12-17 yrs age group; Poonawalla says younger age groups to follow shortlyIt is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
- Covid: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adultsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...
- Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age groupThe Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28. It ha...
- SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Covovax better booster for Covishield-vaccinated people: Dr Shahid Jameel, VirologistIndia is gearing up to tackle a possible third wave of the coronavirus pandemic as the Omicron variant of the virus, which is said to be mu...
- Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
- CDSCO panel recommends emergency use authorisation for SII's Covid vaccine Covovax"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use autho...
- DCGI seeks more data from SII over its application seeking emergency authorisation for CovovaxSerum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restrict...
- Serum Institute seeks DCGI nod for Covid vaccine CovovaxBy Payal Banerjee New Delhi, The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to ...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
Load More
